Bicycle Therapeutics (BCYC) Current Taxes (2018 - 2023)

Bicycle Therapeutics' (BCYC) quarterly Current Taxes came in at $1.9 million in Q2 2023, down 22.49% on a QoQ basis from $2.5 million in Q1 2023.

Bicycle Therapeutics (BCYC) Current Taxes (2018 - 2023) Analysis & Trends

Bicycle Therapeutics (BCYC) has 5 years of Current Taxes data on file, last reported at $1.9 million in Q2 2023.

Quarterly Current Taxes changed N/A year-over-year to $1.9 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.9 million (changed N/A YoY) and the FY2022 annual result came in at $970000.0, changed N/A from the prior year.
Current Taxes slipped to $1.9 million in Q2 2023, from $2.5 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $2.5 million in Q1 2023 to a low of $1000.0 in Q4 2019.
A 4-year average of $803285.7 and a median of $269000.0 in 2019 frame the typical range for Current Taxes.
The widest YoY moves for Current Taxes: up 93.33% in 2019, down 93.33% in 2019.
Tracing BCYC's Current Taxes over 4 years: stood at $1000.0 in 2019, then surged by 600.0% to $7000.0 in 2020, then jumped by 13757.14% to $970000.0 in 2022, then soared by 96.49% to $1.9 million in 2023.
The last three Current Taxes figures came in at $1.9 million (Q2 2023), $2.5 million (Q1 2023), and $970000.0 (Q4 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Bicycle Therapeutics	272.28 Mn	272.28 Mn	-	-

Download Data